Laderian, B., Zhou, M., Luk, L., Bates, S. E., Fojo, A. T., Rivero, J. D. (2025). A phase 2 study of lanreotide as a therapy for pheochromocytomas (PCs) and paragangliomas (PGs).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.10612